Centre for new antibacterial strategies (CANS) is a large interdisciplinary centre at UiT – The Arctic University of Norway for research, education, innovation and dissemination related to antimicrobial resistance (AMR). CANS currently involves sixteen research groups located at three faculties and covers topics within marine bioprospecting – identification and characterization of new antibacterial activities, design and synthesis of new antibiotics and resistance inhibitors, the evolution and molecular epidemiology of AMR, host-microbe-drug interactions, and antibiotic stewardship.
The centre aims to strengthen current activities, but also support new basic research in novel concepts for sustainable antibacterial activities in AMR-prevention and treatment strategies through new permanent and temporary (tenure-track, postdoc and PhD) positions.
Discovery of Antibiotic Resistance in Newly Identified Bacterium
02.12.2024
CANS migrates from X to Bluesky. Click to join us.
04.09.2024
Bacterial breakthrough in the Arctic Sea
Discovery of Antibiotic Resistance in Newly Identified Bacterium
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
Scientists have began to unravel the mysteries of the bacteria discovered in 2020. And there is probably more to come. Foto: Jan Fredrik Frantzen, UiT
In 2020, a research group at UiT The Arctic University of Norway in Tromsø discovered a previously unknown bacterium. You may have heard of Staphylococcus aureus (golden staph), but this one belongs to the white variety.
The newcomer, discovered in Tromsø in Northern Norway, was proudly named Staphylococcus borealis (S. borealis) after the Northern Lights.
But how dangerous is it really, and is it a threat to us at all?
33 Percent Antibiotic Resistance
To investigate, researchers collected bacterial samples stored in freezers at several Norwegian hospitals.
The samples went as far back as 2014, and the researchers conducted new tests to see if they could identify the new bacterium in the old samples. Meanwhile, new samples arriving at the UiT lab from 2020 to 2024 were tested continuously. In total, the researchers collected and analysed 129 samples from seven Norwegian hospitals.
It turns out that S. borealis is resistant to more than three different classes of antibiotics in one-third of the cases where it was tested.
"We see the most resistance against the antibiotic classes fusidic acid, cephalosporins, penicillins, macrolides, and fluoroquinolones," explains Jorunn Pauline Cavanagh, who led the work on bacterial analyses.
Moreover, the bacterium also appears to be highly adept at acquiring protective mechanisms from other bacterial species. This means it could potentially develop antibiotic resistance quickly, when attacked with the medicines currently available.
A Problem for the Elderly
S. borealis is a bacterium that lives on our skin, and researchers have found that it can become problematic when your immune system is weakened. This makes it particularly concerning for the elderly and for those who have had knee or hip replacements.
"This bacterium is an opportunist that can cause illness when your immune system is compromised. For example, we see that it can form what’s called biofilm around knee prostheses and cause infections that can be difficult to treat," explains Jorunn Pauline Cavanagh.
Researchers are now working to determine which diseases this bacterium can cause. Preliminary findings suggest it may lead to urinary tract infections, as well as inflammation in areas where implants are present.
"We do know that it causes mastitis in dromedary camels. This is because we’ve published the bacterium’s genetic profile in international databases, which other researchers use to compare their own bacterial findings. So, more possibilities may emerge," says Cavanagh.
Contact Information
Jorunn Pauline Cavanagh Associate professor at UiT The Arctic University of Norway Phone: +47 40 49 84 90
Researchers from CANS and the research group Marbio have found antibacterial compounds in the Barents Sea, a new study shows.
Dr. Yannik Schneider from UiT, CANS, and the research group Marbio. Foto: Teppo Rämä
During a research trip off Svalbard with the Norwegian research vessel FF Kronprins Haakon in 2020, UiT researchers came across actinobacteria in sediments and marine life. After laboratory analysis, the researchers have concluded that the bacteria contain compunds that disarm enteropathogenic E. coli bacteria, which is responsible for intestinal infections and infant mortality in developing countries.